David Brennan
Director/Board Member en INSMED INCORPORATED .
Fortuna: 2 M $ al 31/03/2024
Perfil
David Richard Brennan es un empresario que ha estado al frente de 6 empresas diferentes. Es presidente de Alexion Pharmaceuticals, Inc. También forma parte del consejo de Insmed, Inc., del Gettysburg College y de la Asociación de Orquestas de Filadelfia. En el pasado, el Sr. Brennan ocupó los cargos de Consejero Delegado y Director Ejecutivo de AstraZeneca Plc, Presidente y Consejero Delegado de AstraZeneca LP y Vicepresidente Senior de Planificación y Desarrollo de Negocio de Astra Pharmaceuticals LP (todas ellas filiales de AstraZeneca Plc), Director General de Chibret International en Merck & Co, Miembro de la Mesa Redonda Europea de Industriales, Comisario de la Comisión de Empleo y Competencias del Reino Unido, Presidente de la Sección del Sureste de Pensilvania de la Asociación Americana del Corazón (Nueva York), Presidente y Tesorero de Pharmaceutical Research & Manufacturers of America, Vicepresidente de la Federación Internacional de Fabricantes Farmacéuticos y Miembro del Consejo Ejecutivo de la Federación Europea de Industrias y Asociaciones Farmacéuticas. El Sr. Brennan se licenció en el Gettysburg College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
INSMED INCORPORATED
0.05% | 11/05/2023 | 80 876 ( 0.05% ) | 2 M $ | 31/03/2024 |
Cargos activos de David Brennan
Empresas | Cargo | Inicio |
---|---|---|
INSMED INCORPORATED | Director/Board Member | 29/05/2014 |
Gettysburg College | Director/Board Member | - |
Antiguos cargos conocidos de David Brennan.
Empresas | Cargo | Fin |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Chief Executive Officer | 27/03/2017 |
ASTRAZENECA PLC | Chief Executive Officer | 01/06/2012 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Chief Executive Officer | 01/06/2012 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | President | 01/01/2012 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Chief Executive Officer | 01/01/2012 |
Formación de David Brennan.
Gettysburg College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
RELX PLC | Commercial Services |
INSMED INCORPORATED | Health Technology |
Empresas privadas | 14 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Commercial Services |
European Round Table of Industrialists | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Astra Pharmaceuticals LP | |
UK Commission for Employment & Skills | Commercial Services |
American Heart Association (New York)
American Heart Association (New York) Miscellaneous Commercial ServicesCommercial Services Part of American Heart Association, Inc., American Heart Association (New York) provides public health educational services. The private company is based in New York, NY. | Commercial Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Health Technology |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Innocoll Holdings Plc
Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Innocoll Holdings Plc operates as a pharmaceutical company. It focuses on the development and commercialization of pharmaceutical technologies to meet healthcare challenges. The firm's late-stage product pipeline is focused on addressing patient needs for postsurgical pain management. The company was founded in 1997 and is headquartered in Athlone, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- David Brennan